Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism RORG antagonists(Nuclear receptor ROR-gamma antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 2 | PL | 17 Jan 2019 | |
Plaque psoriasis | Phase 2 | CA | 17 Jan 2019 | |
Plaque psoriasis | Phase 2 | US | 17 Jan 2019 | |
Autoimmune Diseases | Phase 1 | - | - | |
Hypersensitivity | Phase 1 | - | - |
Phase 2 | 152 | (JTE-451 200 mg Twice Daily) | csakfxosxz(iurvzyfbwm) = fyjlragiip znjerddpvg (njumjxtpgl, eyjdwqvzdt - aqvucmgslp) View more | - | 16 Aug 2021 | ||
(JTE-451 400 mg Twice Daily) | csakfxosxz(iurvzyfbwm) = jrtwdclgud znjerddpvg (njumjxtpgl, evqyqfkdjh - ekdiwdvyfl) View more |